Cancer Treatment Research in Massachusetts
Cancer Treatment Research (93.395) awarded $568 million to recipients in Massachusetts in 271 grants from fiscal 2021 to 2025, 10% of the program's national total. Dana-Farber Cancer Institute, Inc. received the most, $183 million.
- Awarded in Massachusetts$568 million
- Awards271
- Share of the program10%
- Rank among states3rd of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 136 | $105 million |
| FY 2022 | 159 | $109 million |
| FY 2023 | 141 | $110 million |
| FY 2024 | 150 | $120 million |
| FY 2025 | 144 | $123 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Dana-Farber Cancer Institute, Inc. | Nonprofits | 67 | $183 million |
| Brigham & Womens Hospital Inc | Nonprofits | 28 | $118 million |
| The General Hospital Corporation | Nonprofits | 63 | $109 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 18 | $25.9 million |
| Massachusetts Institute of Technology | Colleges and universities | 8 | $14.9 million |
| The Broad Institute, Inc | Nonprofits | 5 | $11.3 million |
| University of Massachusetts Medical School | Colleges and universities | 8 | $10.9 million |
| The Children's Hospital Corporation | Nonprofits | 11 | $9.5 million |
| Boston Immune Technologies and Therapeutics Inc. | Small businesses | 1 | $6.4 million |
| Reveal Pharmaceuticals, Inc | Small businesses | 2 | $6.1 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Massachusetts?
$568 million from fiscal 2021 to 2025, across 271 awards. Massachusetts ranks 3rd of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Massachusetts?
The largest recipient is Dana-Farber Cancer Institute, Inc., with $183 million in 67 awards. Next are Brigham & Womens Hospital Inc and The General Hospital Corporation.
Can organizations in Massachusetts apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research